The Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:
in Part A, entry 12 on lambda-cyhalothrin is deleted;
in Part E, the following entry is added:
[Further details on identity and specification of active substance are provided in the review report.]
Common Name, Identification Numbers | IUPAC Name | Purity | Date of approval | Expiration of approval | Specific provisions
‘5 |
Lambda-Cyhalothrin
CAS No 91465-08-6
CIPAC No 463
A 1:1 mixture of:
(R)-α-cyano-3-phenoxybenzyl (1S,3S)-3-[(Z)-2-chloro-3,3,3-trifluoropropenyl]-2,2-dimethylcyclopropanecarboxylate and (S)-α-cyano-3-phenoxybenzyl (1R,3R)-3-[(Z)-2-chloro-3,3,3-trifluoropropenyl]-2,2-dimethylcyclopropanecarboxylate or of (R)-α-cyano-3-phenoxybenzyl (1S)-cis-3-[(Z)-2-chloro-3,3,3-trifluoropropenyl]-2,2-dimethylcyclopropanecarboxylate and (S)-α-cyano-3-phenoxybenzyl (1R)-cis-3-[(Z)-2-chloro-3,3,3-trifluoropropenyl]-2,2-dimethylcyclopropanecarboxylate
900 g/kg | 1 April 2016 | 31 March 2023 |
For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on lambda-cyhalothrin, and in particular Appendices I and II thereof, shall be taken into account.
In this overall assessment Member States shall pay particular attention to the:
protection of operators, workers and bystanders;
metabolites potentially formed in processed commodities;
risk to aquatic organisms, mammals and non-target arthropods.
Conditions of use shall include risk mitigation measures, where appropriate.
The applicants shall submit confirmatory information as regards:
a systematic review to assess the evidence available as regards potential sperm effects linked to exposure to lambda-cyhalothrin using guidance available (e.g. EFSA GD on Systematic Review methodology, 2010);
toxicological information to assess the toxicological profile of the metabolites V (PBA) and XXIII (PBA(OH)).
The applicants shall submit those information to the Commission, the Member States and the Authority by 1 April 2018.’